SCIENTIFIC HUB

Follow the evidence.

15.451 articles found

Open access

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.

Henderson EJ, Henderson EJ, Lord SR, Close JC, Lawrence AD, Whone A, Ben-Shlomo Y.

BMC Neurol · 2013-12-03

DOI: 10.1186/1471-2377-13-188PMID: 24299497

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials.

Vallano A, Fernandez-Duenas V, Garcia-Negredo G, Quijada MA, Simon CP, Cuffí ML, Carbonell L, Sanchez S, Arnau JM, Ciruela F.

CNS Neurol Disord Drug Targets · 2013-12-01

DOI: 10.2174/18715273113129990115PMID: 24040811

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.